Pre-eclampsia disrupts the normal relationship between serum leptin concentrations and adiposity in pregnant women

Paediatric and Perinatal Epidemiology

Volumn 13, Issue 2, 1999, Pages 190-204

  Williams, Michelle A ^a,c,e   Havel, Peter J ^b   Schwartz, Michael W ^c,d   Leisenring, Wendy M ^e   King, Irena B G ^e   Zingheim, Rosalee W ^a   Zebelman, Arthur M ^f   Luthy, David A ^a  

^a SWEDISH MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^e Fred Hutchinson Cancer Research Center   (United States)

^f DYNACARE LABORATORIES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN;

ADULT; ARTICLE; BODY MASS; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; OBESITY; PLACENTA; PREECLAMPSIA; PROTEINURIA; RADIOIMMUNOASSAY; REGRESSION ANALYSIS; RISK; SECOND TRIMESTER PREGNANCY;

ADIPOSE TISSUE; ADOLESCENT; ADULT; BLOOD PRESSURE; BODY MASS INDEX; CASE-CONTROL STUDIES; COHORT STUDIES; CONFOUNDING FACTORS (EPIDEMIOLOGY); FEMALE; HUMANS; LEPTIN; OBESITY; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PROTEINS; RISK FACTORS; STATISTICS; SWEDEN;

EID: 0032950182     PISSN: 02695022     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3016.1999.00175.x     Document Type: Article

References (31)

1. Zuspan FP, Samuels P. Preventing preeclampsia. New England Journal of Medicine 1993; 329:1265-1266.
2. Roberts JM, Redman CW. Pre-eclampsia: more than pregnancy-induced hypertension. Lancet 1993; 341:1447-1451.
3. Kaaja R, Tikkanen MJ, Vinnikka L, Ylikorkala O. Serum lipoproteins, insulin, and urinary prostanoid metabolites in normal and hypertensive pregnant women. Obstetrics and Gynecology 1995; 85:353-356.
4. Gratacos E, Casals E, Sanllehy C, Cararach V, Alonos PL, Fortuny A. Variation in lipid levels during pregnancy in women with different types of hypertension. Acta Obstetricia et Gynecologica Scandinavica 1996; 75:896-901.
5. Hubel CA, Roberts JM, Taylor RN, Musci TJ, Rogers GM, McLaughlin MK. Lipid peroxidation in pregnancy: new perspectives on preeclampsia. American Journal of Obstetrics and Gynecology 1989; 161:1025-1034.
6. Walsh SW. Lipid peroxidation in pregnancy. Hypertension in Pregnancy 1994; 13:1-32.
7. Schobel HP, Fischer T, Heuszer K, Geiger H, Schmieder RE. Preeclampsia - a state of sympathetic overactivity. New England Journal of Medicine 1996; 335:1480-1485.
8. Kupferminc MJ, Peaceman AM, Wigton TR, Rehnberg BA, Socol ML. Tumor necrosis factor-alpha is elevated in plasma and amniotic fluid of patients with severe preeclampsia. American Journal of Obstetrics and Gynecology 1994; 170:1752-1759.
9. Greer IA, Lyall F, Perera T, Boswell F, Macara LM. Increased concentration of cytokines interleukin-6 and interleukin-1 receptor antagonist in plasma of women with preeclampsia: a mechanism for endothelial dysfunction? Obstetrics and Gynecology 1994; 84:937-940.
10. Sorensen TK, Williams MA, Zingheim RW, Clement SJ, Hickok DE. Elevated second-trimester chorionic gonadotropin and subsequent pregnancy-induced hypertension. American Journal of Obstetrics and Gynecology 1993; 169:834-838.
11. Walsh SW, Michael JB, Allen NH. Placental prostacyclin production in normal and toxemic pregnancies. American Journal of Obstetrics and Gynecology 1985; 151:110-115.
12. FitzGerald DJ, Entman SS, Mulloy K, FitzGerald GA. Decreased prostacyclin biosynthesis preceding the clinical manifestation of pregnancy-induced hypertension. Circulation 1987; 75:956-963.
13. Redman CW. Cytotrophoblasts: Masters of disguise. Nature Medicine 1997; 3:610-611.
14. Mittendorf R, Lain KY, Williams MA, Walker C. Preeclampsia: a nested case-control study of risk factors and their interactions. Journal of Reproductive Medicine 1996; 41:491-496.
15. Eskenazi B, Fenster L, Sidney S. A multivariate analysis of risk factors for preeclampsia. JAMA 1992; 266:237-241.
16. Williams MA, Zingheim RW, King IB, Zebelman AM. Omega-3 fatty acids in maternal erythrocytes and risk of preeclampsia. Epidemiology 1995; 6:232-237.
17. Schwartz MW, Seeley RJ, Campfield LA, Burn P, Baskin DG. Identification of targets of leptin action in rat hypothalamus. Journal of Clinical Investigation 1996; 98:1101-1106.
18. Schwartz MW, Peskind E, Raskind M, Boyko EJ, Porte D. Cerebrospinal fluid leptin levels: Relationship to plasma levels and to adiposity in humans. Nature Medicine 1996; 2:589-593.
19. Havel PJ, Kasim-Karakas S, Mueller WM, Johnson PR, Gingerich RL, Stern JS. Relationship of plasma leptin to plasma insulin and adiposity in normal weight and overweight women: Effects of dietary fat content and sustained weight loss. Journal of Clinical Endocrinology and Metabolism 1996; 81:4406-4413.
20. Weigle DS, Duell PB, Connor WE, Steiner RA, Soules MR, Kuipjer JL. Effect of fasting, re-feeding, and dietary fat restriction on plasma leptin levels. Journal of Clinical Endocrinology and Metabolism 1997; 82:561-565.
21. Masusaki H, Ogawa Y, Sagawa N, Hosoda K, Matsumoto T, Mise H, et al. Nonadipose tissue production of leptin: leptin as a novel placental-derived hormone in humans. Nature Medicine 1997; 3:1029-1033.
22. Schubring C, Kiess W, Englaro P, Rascher W, Dotsch J, Hanitsch S, et al. Levels of leptin in maternal serum, amniotic fluid, and arterial and venous cord blood: relation to neonatal and placental weight. Journal of Clinical Endocrinology and Metabolism 1997; 82:1480-1483.
23. Butte NF, Hopkinson JM, Nicolson MA. Leptin in human reproduction: serum leptin levels in pregnant and lactating women. Journal of Clinical Endocrinology and Metabolism 1997; 82:585-589.
24. Senaris R, Garcia-Caballero T, Casabiell X, Gallego R, Castro R, Considine RV, et al. Synthesis of leptin in human placenta Endocrinology 1997; 138:4501-4505.
25. American College of Obstetricians and Gynecologists. Management of preeclampsia. Technical Bulletin. No. 19, 1986.
26. Ma ZA, Gingerich RL, Santiago JV, Klein S, Smith HC, Landt M. Radioimmunoassay of leptin in human plasma. Clinical Chemistry 1996; 42:942-946.
27. Hartman BA, Wagenbichler P, Soregi G. Maternal and umbilical-cord serum leptin concentrations in normal, full-term pregnancies (Letter). New England Journal of Medicine 1997; 337:863.
28. McCarthy JF, Patrick TE, Lykins DL, DeVaskar SU, Rajakumar PA, Roberts JM. Leptin concentration is higher in the plasma of preeclamptic women compared to pregnant controls matched for body mass index (BMI) and gestational age (Abstract). Journal of the Society of Gynecologic Investigation 1997; 4(Suppl.):247A.
29. Chien EK, Hara M, Rouard M, Yano H, Phillippe M, Polonsky KS, et al. Increase in serum leptin and uterine leptin receptor messenger RNA levels during pregnancy in rats. Biochemical and Biophysical Research Communications 1997; 237:476-480.
30. Snitker S, Pratley RE, Nicolson M, Tataranni PA, Ravussin E. Relationship between muscle sympathetic nerve activity and plasma leptin concentration. Obesity Research 1997; 5:338-340.
31. Haynes WG, Morgan DA, Walsh SA, Mark AL, Sivitz WI. Receptor-mediated regional sympathetic nerve action by leptin. Journal of Clinical Investigation 1997; 100:270-278.